APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgen and Anabolic Steroid

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Androgen and Anabolic Steroid Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchAndrogen and Anabolic Steroid Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgen and Anabolic Steroid Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Androgen and Anabolic Steroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgen and Anabolic Steroid Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgen and Anabolic Steroid Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Androgen and Anabolic Steroid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Androgen and Anabolic Steroid market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Androgen and Anabolic Steroid market include Acerus Pharmaceuticals, Amneal Pharmaceuticals, Antares Pharma, Auxilium Pharmaceuticals, Bausch Health, Clarus Therapeutics, Endo Pharmaceuticals, Pharmacia and Upjohn and Solvay Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Androgen and Anabolic Steroid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Androgen and Anabolic Steroid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Androgen and Anabolic Steroid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Androgen and Anabolic Steroid market size, projected growth trends, production technologies, key applications, and end-use industries.

Androgen and Anabolic Steroid Segment by Company

Acerus Pharmaceuticals

Amneal Pharmaceuticals

Antares Pharma

Auxilium Pharmaceuticals

Bausch Health

Clarus Therapeutics

Endo Pharmaceuticals

Pharmacia and Upjohn

Solvay Pharmaceuticals

Upsher-Smith

AbbVie

GlaxoSmithKline

Pfizer

Teva

Androgen and Anabolic Steroid Segment by Type

Methyltestosterone

Testosterone

Fluoxymesterone

Others

Androgen and Anabolic Steroid Segment by Application

Hospitals

Pharmacy

Others

Androgen and Anabolic Steroid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Androgen and Anabolic Steroid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Androgen and Anabolic Steroid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Androgen and Anabolic Steroid significant trends, drivers, influence factors in global and regions.

6. To analyze Androgen and Anabolic Steroid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgen and Anabolic Steroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgen and Anabolic Steroid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgen and Anabolic Steroid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Androgen and Anabolic Steroid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Androgen and Anabolic Steroid industry.

Chapter 3: Detailed analysis of Androgen and Anabolic Steroid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Androgen and Anabolic Steroid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Androgen and Anabolic Steroid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Androgen and Anabolic Steroid Industry Trends Table 2. Androgen and Anabolic Steroid Industry Drivers Table 3. Androgen and Anabolic Steroid Industry Opportunities and Challenges Table 4. Androgen and Anabolic Steroid Industry Restraints Table 5. Global Androgen and Anabolic Steroid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Androgen and Anabolic Steroid Revenue Share by Company (2021-2026) Table 7. Global Androgen and Anabolic Steroid Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Androgen and Anabolic Steroid Sales Volume Share by Company (2021-2026) Table 9. Global Androgen and Anabolic Steroid Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Androgen and Anabolic Steroid Company Ranking, (2024-2026) & (USD Million) Table 11. Global Androgen and Anabolic Steroid Key Company Manufacturing Base & Headquarters Table 12. Global Androgen and Anabolic Steroid Company, Product Type & Application Table 13. Global Androgen and Anabolic Steroid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Androgen and Anabolic Steroid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Methyltestosterone Table 18. Significant Companies of Testosterone Table 19. Significant Companies of Fluoxymesterone Table 20. Significant Companies of Others Table 21. Global Androgen and Anabolic Steroid Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Androgen and Anabolic Steroid Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Androgen and Anabolic Steroid Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Androgen and Anabolic Steroid Sales Volume Share by Type (2021-2026) Table 25. Global Androgen and Anabolic Steroid Sales Volume Share by Type (2027-2032) Table 26. Global Androgen and Anabolic Steroid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Androgen and Anabolic Steroid Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Androgen and Anabolic Steroid Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Androgen and Anabolic Steroid Sales Value Share by Type (2021-2026) Table 30. Global Androgen and Anabolic Steroid Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Pharmacy Table 33. Significant Companies of Others Table 34. Global Androgen and Anabolic Steroid Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Androgen and Anabolic Steroid Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Androgen and Anabolic Steroid Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Androgen and Anabolic Steroid Sales Volume Share by Application (2021-2026) Table 38. Global Androgen and Anabolic Steroid Sales Volume Share by Application (2027-2032) Table 39. Global Androgen and Anabolic Steroid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Androgen and Anabolic Steroid Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Androgen and Anabolic Steroid Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Androgen and Anabolic Steroid Sales Value Share by Application (2021-2026) Table 43. Global Androgen and Anabolic Steroid Sales Value Share by Application (2027-2032) Table 44. Global Androgen and Anabolic Steroid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Androgen and Anabolic Steroid Sales by Region (2021-2026) & (K Units) Table 46. Global Androgen and Anabolic Steroid Sales Market Share by Region (2021-2026) Table 47. Global Androgen and Anabolic Steroid Sales by Region (2027-2032) & (K Units) Table 48. Global Androgen and Anabolic Steroid Sales Market Share by Region (2027-2032) Table 49. Global Androgen and Anabolic Steroid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Androgen and Anabolic Steroid Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Androgen and Anabolic Steroid Sales Value Share by Region (2021-2026) Table 52. Global Androgen and Anabolic Steroid Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Androgen and Anabolic Steroid Sales Value Share by Region (2027-2032) Table 54. Global Androgen and Anabolic Steroid Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Androgen and Anabolic Steroid Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Androgen and Anabolic Steroid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Androgen and Anabolic Steroid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 59. Global Androgen and Anabolic Steroid Sales Market Share by Country (2021-2026) Table 60. Global Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 61. Global Androgen and Anabolic Steroid Sales Market Share by Country (2027-2032) Table 62. Global Androgen and Anabolic Steroid Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Androgen and Anabolic Steroid Sales Value Market Share by Country (2021-2026) Table 64. Global Androgen and Anabolic Steroid Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Androgen and Anabolic Steroid Sales Value Market Share by Country (2027-2032) Table 66. Acerus Pharmaceuticals Company Information Table 67. Acerus Pharmaceuticals Business Overview Table 68. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 70. Acerus Pharmaceuticals Recent Development Table 71. Amneal Pharmaceuticals Company Information Table 72. Amneal Pharmaceuticals Business Overview Table 73. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 75. Amneal Pharmaceuticals Recent Development Table 76. Antares Pharma Company Information Table 77. Antares Pharma Business Overview Table 78. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Antares Pharma Androgen and Anabolic Steroid Product Portfolio Table 80. Antares Pharma Recent Development Table 81. Auxilium Pharmaceuticals Company Information Table 82. Auxilium Pharmaceuticals Business Overview Table 83. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 85. Auxilium Pharmaceuticals Recent Development Table 86. Bausch Health Company Information Table 87. Bausch Health Business Overview Table 88. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bausch Health Androgen and Anabolic Steroid Product Portfolio Table 90. Bausch Health Recent Development Table 91. Clarus Therapeutics Company Information Table 92. Clarus Therapeutics Business Overview Table 93. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio Table 95. Clarus Therapeutics Recent Development Table 96. Endo Pharmaceuticals Company Information Table 97. Endo Pharmaceuticals Business Overview Table 98. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 100. Endo Pharmaceuticals Recent Development Table 101. Pharmacia and Upjohn Company Information Table 102. Pharmacia and Upjohn Business Overview Table 103. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio Table 105. Pharmacia and Upjohn Recent Development Table 106. Solvay Pharmaceuticals Company Information Table 107. Solvay Pharmaceuticals Business Overview Table 108. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 110. Solvay Pharmaceuticals Recent Development Table 111. Upsher-Smith Company Information Table 112. Upsher-Smith Business Overview Table 113. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Upsher-Smith Androgen and Anabolic Steroid Product Portfolio Table 115. Upsher-Smith Recent Development Table 116. AbbVie Company Information Table 117. AbbVie Business Overview Table 118. AbbVie Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. AbbVie Androgen and Anabolic Steroid Product Portfolio Table 120. AbbVie Recent Development Table 121. GlaxoSmithKline Company Information Table 122. GlaxoSmithKline Business Overview Table 123. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio Table 125. GlaxoSmithKline Recent Development Table 126. Pfizer Company Information Table 127. Pfizer Business Overview Table 128. Pfizer Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Pfizer Androgen and Anabolic Steroid Product Portfolio Table 130. Pfizer Recent Development Table 131. Teva Company Information Table 132. Teva Business Overview Table 133. Teva Androgen and Anabolic Steroid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Teva Androgen and Anabolic Steroid Product Portfolio Table 135. Teva Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Androgen and Anabolic Steroid Distributors List Table 139. Androgen and Anabolic Steroid Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Androgen and Anabolic Steroid Product Image Figure 2. Global Androgen and Anabolic Steroid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androgen and Anabolic Steroid Sales Value (2021-2032) & (US$ Million) Figure 4. Global Androgen and Anabolic Steroid Sales (2021-2032) & (K Units) Figure 5. Global Androgen and Anabolic Steroid Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Androgen and Anabolic Steroid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Methyltestosterone Image Figure 10. Testosterone Image Figure 11. Fluoxymesterone Image Figure 12. Others Image Figure 13. Global Androgen and Anabolic Steroid Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Androgen and Anabolic Steroid Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Androgen and Anabolic Steroid Sales Volume Share by Type (2021-2032) Figure 16. Global Androgen and Anabolic Steroid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Androgen and Anabolic Steroid Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Androgen and Anabolic Steroid Sales Value Share by Type (2021-2032) Figure 19. Hospitals Image Figure 20. Pharmacy Image Figure 21. Others Image Figure 22. Global Androgen and Anabolic Steroid Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Androgen and Anabolic Steroid Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Androgen and Anabolic Steroid Sales Volume Share by Application (2021-2032) Figure 25. Global Androgen and Anabolic Steroid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Androgen and Anabolic Steroid Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Androgen and Anabolic Steroid Sales Value Share by Application (2021-2032) Figure 28. Global Androgen and Anabolic Steroid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Androgen and Anabolic Steroid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Androgen and Anabolic Steroid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Androgen and Anabolic Steroid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Androgen and Anabolic Steroid Sales Value (2021-2032) & (US$ Million) Figure 33. North America Androgen and Anabolic Steroid Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Androgen and Anabolic Steroid Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Androgen and Anabolic Steroid Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Androgen and Anabolic Steroid Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Androgen and Anabolic Steroid Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Androgen and Anabolic Steroid Sales Value (2021-2032) & (US$ Million) Figure 39. South America Androgen and Anabolic Steroid Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Androgen and Anabolic Steroid Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Androgen and Anabolic Steroid Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Androgen and Anabolic Steroid Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Androgen and Anabolic Steroid Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Methyltestosterone
  • Testosterone
  • Fluoxymesterone
  • Others
Applications
  • Hospitals
  • Pharmacy
  • Others
Companies covered
  • Acerus Pharmaceuticals
  • Amneal Pharmaceuticals
  • Antares Pharma
  • Auxilium Pharmaceuticals
  • Bausch Health
  • Clarus Therapeutics
  • Endo Pharmaceuticals
  • Pharmacia and Upjohn
  • Solvay Pharmaceuticals
  • Upsher-Smith
  • AbbVie
  • GlaxoSmithKline
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Androgen and Anabolic Steroid Sales Value (2021-2032)
  4. 1.2.2 Global Androgen and Anabolic Steroid Sales Volume (2021-2032)
  5. 1.2.3 Global Androgen and Anabolic Steroid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Androgen and Anabolic Steroid Market Dynamics
  1. 2.1 Androgen and Anabolic Steroid Industry Trends
  2. 2.2 Androgen and Anabolic Steroid Industry Drivers
  3. 2.3 Androgen and Anabolic Steroid Industry Opportunities and Challenges
  4. 2.4 Androgen and Anabolic Steroid Industry Restraints
3 Androgen and Anabolic Steroid Market by Company
  1. 3.1 Global Androgen and Anabolic Steroid Company Revenue Ranking in 2025
  2. 3.2 Global Androgen and Anabolic Steroid Revenue by Company (2021-2026)
  3. 3.3 Global Androgen and Anabolic Steroid Sales Volume by Company (2021-2026)
  4. 3.4 Global Androgen and Anabolic Steroid Average Price by Company (2021-2026)
  5. 3.5 Global Androgen and Anabolic Steroid Company Ranking (2024-2026)
  6. 3.6 Global Androgen and Anabolic Steroid Company Manufacturing Base and Headquarters
  7. 3.7 Global Androgen and Anabolic Steroid Company Product Type and Application
  8. 3.8 Global Androgen and Anabolic Steroid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Androgen and Anabolic Steroid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Androgen and Anabolic Steroid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Androgen and Anabolic Steroid Market by Type
  1. 4.1 Androgen and Anabolic Steroid Type Introduction
  2. 4.1.1 Methyltestosterone
  3. 4.1.2 Testosterone
  4. 4.1.3 Fluoxymesterone
  5. 4.1.4 Others
  6. 4.2 Global Androgen and Anabolic Steroid Sales Volume by Type
  7. 4.2.1 Global Androgen and Anabolic Steroid Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Androgen and Anabolic Steroid Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Androgen and Anabolic Steroid Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Androgen and Anabolic Steroid Sales Value by Type
  11. 4.3.1 Global Androgen and Anabolic Steroid Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Androgen and Anabolic Steroid Sales Value by Type (2021-2032)
  13. 4.3.3 Global Androgen and Anabolic Steroid Sales Value Share by Type (2021-2032)
5 Androgen and Anabolic Steroid Market by Application
  1. 5.1 Androgen and Anabolic Steroid Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Androgen and Anabolic Steroid Sales Volume by Application
  6. 5.2.1 Global Androgen and Anabolic Steroid Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Androgen and Anabolic Steroid Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Androgen and Anabolic Steroid Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Androgen and Anabolic Steroid Sales Value by Application
  10. 5.3.1 Global Androgen and Anabolic Steroid Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Androgen and Anabolic Steroid Sales Value by Application (2021-2032)
  12. 5.3.3 Global Androgen and Anabolic Steroid Sales Value Share by Application (2021-2032)
6 Androgen and Anabolic Steroid Regional Sales and Value Analysis
  1. 6.1 Global Androgen and Anabolic Steroid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Androgen and Anabolic Steroid Sales by Region (2021-2032)
  3. 6.2.1 Global Androgen and Anabolic Steroid Sales by Region: 2021-2026
  4. 6.2.2 Global Androgen and Anabolic Steroid Sales by Region (2027-2032)
  5. 6.3 Global Androgen and Anabolic Steroid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Androgen and Anabolic Steroid Sales Value by Region (2021-2032)
  7. 6.4.1 Global Androgen and Anabolic Steroid Sales Value by Region: 2021-2026
  8. 6.4.2 Global Androgen and Anabolic Steroid Sales Value by Region (2027-2032)
  9. 6.5 Global Androgen and Anabolic Steroid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Androgen and Anabolic Steroid Sales Value (2021-2032)
  12. 6.6.2 North America Androgen and Anabolic Steroid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Androgen and Anabolic Steroid Sales Value (2021-2032)
  15. 6.7.2 Europe Androgen and Anabolic Steroid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Androgen and Anabolic Steroid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Androgen and Anabolic Steroid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Androgen and Anabolic Steroid Sales Value (2021-2032)
  21. 6.9.2 South America Androgen and Anabolic Steroid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Androgen and Anabolic Steroid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Androgen and Anabolic Steroid Sales Value Share by Country, 2025 VS 2032
7 Androgen and Anabolic Steroid Country-level Sales and Value Analysis
  1. 7.1 Global Androgen and Anabolic Steroid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Androgen and Anabolic Steroid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Androgen and Anabolic Steroid Sales by Country (2021-2032)
  4. 7.3.1 Global Androgen and Anabolic Steroid Sales by Country (2021-2026)
  5. 7.3.2 Global Androgen and Anabolic Steroid Sales by Country (2027-2032)
  6. 7.4 Global Androgen and Anabolic Steroid Sales Value by Country (2021-2032)
  7. 7.4.1 Global Androgen and Anabolic Steroid Sales Value by Country (2021-2026)
  8. 7.4.2 Global Androgen and Anabolic Steroid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Androgen and Anabolic Steroid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Androgen and Anabolic Steroid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Androgen and Anabolic Steroid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Acerus Pharmaceuticals
  2. 8.1.1 Acerus Pharmaceuticals Company Information
  3. 8.1.2 Acerus Pharmaceuticals Business Overview
  4. 8.1.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  6. 8.1.5 Acerus Pharmaceuticals Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Antares Pharma
  14. 8.3.1 Antares Pharma Company Information
  15. 8.3.2 Antares Pharma Business Overview
  16. 8.3.3 Antares Pharma Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Antares Pharma Androgen and Anabolic Steroid Product Portfolio
  18. 8.3.5 Antares Pharma Recent Developments
  19. 8.4 Auxilium Pharmaceuticals
  20. 8.4.1 Auxilium Pharmaceuticals Company Information
  21. 8.4.2 Auxilium Pharmaceuticals Business Overview
  22. 8.4.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  24. 8.4.5 Auxilium Pharmaceuticals Recent Developments
  25. 8.5 Bausch Health
  26. 8.5.1 Bausch Health Company Information
  27. 8.5.2 Bausch Health Business Overview
  28. 8.5.3 Bausch Health Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bausch Health Androgen and Anabolic Steroid Product Portfolio
  30. 8.5.5 Bausch Health Recent Developments
  31. 8.6 Clarus Therapeutics
  32. 8.6.1 Clarus Therapeutics Company Information
  33. 8.6.2 Clarus Therapeutics Business Overview
  34. 8.6.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio
  36. 8.6.5 Clarus Therapeutics Recent Developments
  37. 8.7 Endo Pharmaceuticals
  38. 8.7.1 Endo Pharmaceuticals Company Information
  39. 8.7.2 Endo Pharmaceuticals Business Overview
  40. 8.7.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  42. 8.7.5 Endo Pharmaceuticals Recent Developments
  43. 8.8 Pharmacia and Upjohn
  44. 8.8.1 Pharmacia and Upjohn Company Information
  45. 8.8.2 Pharmacia and Upjohn Business Overview
  46. 8.8.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio
  48. 8.8.5 Pharmacia and Upjohn Recent Developments
  49. 8.9 Solvay Pharmaceuticals
  50. 8.9.1 Solvay Pharmaceuticals Company Information
  51. 8.9.2 Solvay Pharmaceuticals Business Overview
  52. 8.9.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  54. 8.9.5 Solvay Pharmaceuticals Recent Developments
  55. 8.10 Upsher-Smith
  56. 8.10.1 Upsher-Smith Company Information
  57. 8.10.2 Upsher-Smith Business Overview
  58. 8.10.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Upsher-Smith Androgen and Anabolic Steroid Product Portfolio
  60. 8.10.5 Upsher-Smith Recent Developments
  61. 8.11 AbbVie
  62. 8.11.1 AbbVie Company Information
  63. 8.11.2 AbbVie Business Overview
  64. 8.11.3 AbbVie Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie Androgen and Anabolic Steroid Product Portfolio
  66. 8.11.5 AbbVie Recent Developments
  67. 8.12 GlaxoSmithKline
  68. 8.12.1 GlaxoSmithKline Company Information
  69. 8.12.2 GlaxoSmithKline Business Overview
  70. 8.12.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio
  72. 8.12.5 GlaxoSmithKline Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Androgen and Anabolic Steroid Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Teva
  80. 8.14.1 Teva Company Information
  81. 8.14.2 Teva Business Overview
  82. 8.14.3 Teva Androgen and Anabolic Steroid Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Teva Androgen and Anabolic Steroid Product Portfolio
  84. 8.14.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Androgen and Anabolic Steroid Value Chain Analysis
  2. 9.1.1 Androgen and Anabolic Steroid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Androgen and Anabolic Steroid Sales Mode & Process
  6. 9.2 Androgen and Anabolic Steroid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Androgen and Anabolic Steroid Distributors
  9. 9.2.3 Androgen and Anabolic Steroid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst